PL EN
RESEARCH PAPER
The Role of Nutritional Supplementation and Lifestyle Modification in Patients with Vitreous Floaters
 
 
 
More details
Hide details
1
Department of Retinal and Vitreous Surgery
 
2
University Clinical Hospital No. 1
 
3
Medical University of Lublin, Poland
 
 
Publication date: 2025-07-02
 
 
Ophthalmology 2025;28(1):28-32
 
KEYWORDS
ABSTRACT
Vitreous floaters are a common condition resulting from the physiological ageing process and degenerative changes that lead to the liquefaction and loosening of the vitreous body structure. Although they usually do not threaten visual acuity, they can significantly reduce visual comfort. Diagnostic methods include optical coherence tomography and ultrasound examinations. Surgical treatments, such as vitrectomy or laser vitreolysis, carry risks of complications, so conservative approaches are increasingly emphasized. A healthy lifestyle, protection against oxidative stress, and the use of dietary supplements containing antioxidants, vitamins, and minerals that support eye health are recommended.
FUNDING
no external funding
CONFLICT OF INTEREST
none declared
REFERENCES (24)
1.
Gouliopoulos N, Oikonomou D, Karygianni F, et al.: The association of symptomatic vitreous floaters with depression and anxiety. Int Ophthalmol. 2024 May 7; 44(1): 218.
 
2.
Uchino E, Uemura A, Ohba N: Initial stages of posterior vitreous detachment in healthy eyes of older persons evaluated by optical coherence tomography. Arch Ophthalmol. 2001 Oct; 119(10): 1475–1479.
 
3.
Webb BF, Webb JR, Schroeder MC, et al.: Prevalence of vitreous floaters in a community sample of smartphone users. Int J Ophthalmol. 2013 Jun 18; 6(3): 402–405.
 
4.
Marquez MA, Nadelson A, Magraner M, et al.: Dynamic Infrared Imaging of Vitreous Floaters. Clin Ophthalmol. 2023; 17: 1169–1177.
 
5.
Sobolewski P: Witreoliza laserowa – niedoceniona metoda leczenia zmętnień ciała szklistego. Magazyn Lekarza Okulisty. 2011; 5(1).
 
6.
Łuszczewski A, Matyska-Piekarska E, Trefler J i wsp.: Reaktywne formy tlenu – znaczenie w fizjologii i stanach patologii organizmu. Reumatologia. 2007; 45, 5: 284–289.
 
7.
Sebag J: The vitreous: structure, function, and pathobiology. Springer. 2004.
 
8.
Siegfried CJ, Shui YB, Holekamp NM, et al.: Oxygen distribution in the human eye: relevance to the etiology of open-angle glaucoma after vitrectomy. Invest Ophthalmol Vis Sci. 2010 Nov; 51(11): 5731–5738.
 
9.
Winkler BS, Boulton ME, Gottsch JD, et al.: Oxidative damage and age-related macular degeneration. Mol Vis. 1999 Nov 3; 5: 32.
 
10.
Shu DY, Chaudhary S, Cho KS, et al.: Role of Oxidative Stress in Ocular Diseases: A Balancing Act. Metabolites. 2023; 13(2): 187.
 
11.
Krinsky NI, Landrum JT, Bone RA: Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annu Rev Nutr. 2003; 23: 171–201.
 
12.
Stitt AW: Advanced glycation: an important pathological event in diabetic and age related ocular disease. Br J Ophthalmol. 2001 Jun; 85(6): 746–753.
 
13.
Sulochana KN, Ramprasad S, Coral K, et al.: Glycation and glycoxidation studies in vitro on isolated human vitreous collagen. Med Sci Monit. 2003 Jun; 9(6): BR220–224.
 
14.
Nakazawa Y, Aoki M, Doki Y, et al.: Oral consumption of α-glucosyl-hesperidin could prevent lens hardening, which causes presbyopia. Biochem Biophys Rep. 2020 Dec 26; 25: 100885.
 
15.
Choo PP, Woi PJ, Bastion MC, et al.: Review of Evidence for the Usage of Antioxidants for Eye Aging. Biomed Res Int. 2022 Oct 3; 2022: 5810373.
 
16.
Taylor A, Jacques PF, Nadler D, et al.: Relationship in humans between ascorbic acid consumption and levels of total and reduced ascorbic acid in lens, aqueous humor, and plasma. Curr Eye Res. 1991 Aug; 10(8): 751–759.
 
17.
Ugarte M, Osborne N, Brown LA, et al.: Iron, zinc, and copper in retinal physiology and disease. Survey of Ophthalmology. 2013; Volume 58, Issue 6: 585–609.
 
18.
Smailhodzic D, van Asten F, Blom AM, et al.: Zinc supplementation inhibits complement activation in age-related macular degeneration. PLoS One. 2014 Nov 13; 9(11): e112682.
 
19.
Dharamdasani DH, Mitchell P, Russell J, et al.: Dietary zinc intake is associated with macular fluid in neovascular age-related macular degeneration. Clin Exp Ophthalmol. 2020 Jan; 48(1): 61–68.
 
20.
Del Bo‘ C, Bernardi S, Marino M, et al.: Systematic Review on Polyphenol Intake and Health Outcomes: Is there Sufficient Evidence to Define a Health-Promoting Polyphenol-Rich Dietary Pattern? Nutrients. 2019 Jun 16; 11(6): 1355.
 
21.
Cipolletta S, Beccarello A, Galan A: A psychological perspective of eye floaters. Qual Health Res. 2012 Nov; 22(11): 1547–1558.
 
22.
Wagle AM, Lim WY, Yap TP, et al.: Utility values associated with vitreous floaters. Am J Ophthalmol. 2011 Jul; 152(1): 60–65.e1.
 
23.
Emmanuel A, Green-Gomez M, Roche W, et al.: Dietary Intervention With a Targeted Micronutrient Formulation Reduces the Visual Discomfort Associated With Vitreous Degeneration. Trans Vis Sci Tech. 2021; 10(12): 19.
 
24.
Sobol M, Osęka M, Kaercher T, et al.: The effect of oral supplementation with L-lysin, hesperidin, proanthodyanidins, vitamin C and Zinc on subjects assessment of the quality of vision in patients with witreous floaters. BON 2018, Warsaw Medical Unive.
 
eISSN:1689-362X
ISSN:1505-2753
Journals System - logo
Scroll to top